Loss of p63 expression is associated with tumor progression in bladder cancer.
暂无分享,去创建一个
C. Cordon-Cardo | F. McKeon | C. J. Di Como | T. Ince | C. Crum | D. Verbel | Ming-Lan Lu | E. Charytonowicz | M. J. Urist
[1] C. Cordon-Cardo,et al. p63 expression profiles in human normal and tumor tissues. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] Moshe Oren,et al. The p53 and Mdm2 families in cancer. , 2002, Current opinion in genetics & development.
[3] W. Kaelin,et al. p53 family update: p73 and p63 develop their own identities. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[4] C. Cordon-Cardo,et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. , 2001, The American journal of pathology.
[5] R Montironi,et al. p63 is a prostate basal cell marker and is required for prostate development. , 2000, The American journal of pathology.
[6] A. Yang,et al. p63 and p73: p53 mimics, menaces and more , 2000, Nature Reviews Molecular Cell Biology.
[7] F. McKeon,et al. Stratified Mucin-Producing Intraepithelial Lesions of the Cervix: Adenosquamous or Columnar Cell Neoplasia? , 2000, The American journal of surgical pathology.
[8] P. Hall,et al. Characterization of the expression pattern of p63α and δnp63α in benign and malignant oral epithelial lesions , 2000 .
[9] A. Yang,et al. Down-regulation of p63 is required for epidermal UV-B-induced apoptosis. , 2000, Cancer research.
[10] T. Crook,et al. High level expression of ΔN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? , 2000, Oncogene.
[11] S. Chi,et al. Frequent alteration of p63 expression in human primary bladder carcinomas. , 2000, Cancer research.
[12] R. Knight,et al. p63 and p73 transactivate differentiation gene promoters in human keratinocytes. , 2000, Biochemical and biophysical research communications.
[13] J. Jen,et al. Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma , 2000, International journal of cancer.
[14] J. Jen,et al. AIS is an oncogene amplified in squamous cell carcinoma. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[15] F. Carey,et al. Expression of the p53 homologue p63alpha and deltaNp63alpha in normal and neoplastic cells. , 2000, Carcinogenesis.
[16] F. McKeon,et al. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. , 1999, The Journal of investigative dermatology.
[17] Christopher P. Crum,et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.
[18] H. Vogel,et al. p63 is a p53 homologue required for limb and epidermal morphogenesis , 1999, Nature.
[19] C. Ihm,et al. Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis. , 1999, Cancer genetics and cytogenetics.
[20] T C Gasser,et al. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. , 1999, Cancer research.
[21] C. Prives,et al. p73 Function Is Inhibited by Tumor-Derived p53 Mutants in Mammalian Cells , 1999, Molecular and Cellular Biology.
[22] A. Yang,et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.
[23] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[24] P. Hall,et al. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. , 2000, International journal of cancer.
[25] P. Lichter,et al. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. , 1995, The American journal of pathology.